{
  "meta": {
    "source": "synthetic_generator",
    "version": "1.0"
  },
  "data": {
    "detail": {
      "patient": {
        "structured": {
          "age_value__v": 17,
          "weight_value__v": 70.3,
          "gender_value__v": "Other"
        }
      },
      "case_product__v": {
        "structured": [
          {
            "product_name__v": "Atorvastatin",
            "dose__v": "2 tablet(s) daily",
            "indication__v": "sign"
          }
        ]
      },
      "case_adverse_event__v": {
        "structured": [
          {
            "event_reported__v": "Anxiety",
            "outcome__v": "Not Recovered",
            "serious__v": "No",
            "country__v": "AU",
            "onset_idate__v": "1994-02-26"
          },
          {
            "event_reported__v": "Shortness of Breath",
            "outcome__v": "Unknown",
            "serious__v": "Yes",
            "country__v": "US",
            "onset_idate__v": "1995-01-27"
          },
          {
            "event_reported__v": "Headache",
            "outcome__v": "Not Recovered",
            "serious__v": "Yes",
            "country__v": "DE",
            "onset_idate__v": "1992-03-05"
          }
        ]
      },
      "structured": {
        "narrative__v": "Joshua Medina was prescribed Atorvastatin for during and later developed anxiety along with other symptoms.",
        "report_type__v": "Literature",
        "seriousness_criteria__v": "Hospitalization",
        "receipt_method__v": "Web",
        "transmission_type__v": "Initial"
      }
    }
  }
}